KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Bio-enhanced Curcumin Soft Gelatin Capsule (Synonym: D06892)	2件: Curcumin, Gelatin	2件: D00115 , D06892	-	-	1件: 97
2	Gelatin (Synonym: D06892)	1件: Gelatin	2件: D00115 , D06892	-	-	5件: 28, 62, 78, 97, 269
3	Neoral Soft Gelatin Capsules (Synonym: D06892)	2件: Cyclosporine, Gelatin	3件: D00115 , D00184 , D06892	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬	2件: 97, 269
4	Tafamidis meglumine 20 mg soft gelatin capsules (Synonym: D06892)	3件: Gelatin, Meglumine, Tafamidis	4件: D00115 , D01796 , D06892 , D09673	1件: TTR 💬	1件: Thyroid hormone synthesis 💬	1件: 28
5	Tafamidis Meglumine 20mg Soft Gelatin Capsule (Clinical trial image) (Synonym: D06892)	3件: Gelatin, Meglumine, Tafamidis	4件: D00115 , D01796 , D06892 , D09673	1件: TTR 💬	1件: Thyroid hormone synthesis 💬	1件: 28
6	Tafamidis Meglumine 20mg Soft Gelatin Capsule (Commerical image) (Synonym: D06892)	3件: Gelatin, Meglumine, Tafamidis	4件: D00115 , D01796 , D06892 , D09673	1件: TTR 💬	1件: Thyroid hormone synthesis 💬	1件: 28